AVONEX

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug AVONEX contains one active pharmaceutical ingredient (API):

1	Interferon beta-1a UNII XRO4566Q4R - INTERFERON BETA-1A
	Interferon beta-1a exerts its biological effects by binding to specific receptors on the surface of human cells. This binding initiates a complex cascade of intracellular events that leads to the expression of numerous interferon-induced gene products and markers. Whether the mechanism of action of interferon beta-1a in MS is mediated by the same pathway as the biological effects described above is not known because the pathophysiology of MS is not well established.
	Read more about Interferon beta-1a

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AVONEX Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L03AB07	Interferon beta-1a	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8805K
BR	Câmara de Regulação do Mercado de Medicamentos	538300102150413
CA	Health Products and Food Branch	02269201
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28726-02-09
EE	Ravimiamet	1036369, 1212893, 1299944, 1591286, 1591297
ES	Centro de información online de medicamentos de la AEMPS	97033005
FI	Lääkealan turvallisuus- ja kehittämiskeskus	017234, 412547
FR	Base de données publique des médicaments	62493653, 66674494
GB	Medicines & Healthcare Products Regulatory Agency	140717, 193768, 195627, 51844
HK	Department of Health Drug Office	62261
IE	Health Products Regulatory Authority	88251, 88285, 88286
IL	מִשְׂרַד הַבְּרִיאוּת	7370
JP	医薬品医療機器総合機構	6399422G1027, 6399422G2023
LT	Valstybinė vaistų kontrolės tarnyba	1004450, 1005046, 1015687, 1063637, 1063638
NL	Z-Index G-Standaard, PRK	106356, 71021
NZ	Medicines and Medical Devices Safety Authority	11066, 14931, 7717
PL	Rejestru Produktów Leczniczych	100092430, 100127111
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65147001, W65147002, W65231001
TN	Direction de la Pharmacie et du Médicament	10913012H, 10913013H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699783950033
ZA	Health Products Regulatory Authority	32/34/0743, A40/34/0502